Novavax Closes Offering For 6.8 Million Shares
Novavax closes public offering for 6.8 million shares, nets $21 million in proceeds
11:01AM 12/09/09
NOVAVAX Announces Closing Of Public Offering Of 6,800,000 Shares Of Common Stock
09:00AM 12/09/09
SeaChange, Tenet: Early Volume Plays
Several stocks trading near $5 were poised to move on above-average volume during Thursday's session.
08:37AM 12/03/09
Dyax, RF Micro: Early Volume Plays
Several stocks trading near $5 were poised to move on above-average volume during Wednesday's session
08:40AM 12/02/09
Novavax Swine Flu Vaccine Meets Study Goal
Novavax says developing swine flu vaccine meets midstage study goal
08:27AM 12/02/09
NOVAVAX Reports Positive Clinical Results From Pivotal Study Of H1N1 Influenza Vaccine In Mexico
- Independent Data and Safety Monitoring Board (DSMB) finds that a single dose of 15 mcg or 45 mcg of H1N1 VLP is well tolerated and produces a robust immune response
08:05AM 12/02/09
Anthracite, Netlist: Early Volume Plays
Several stocks trading under $5 were poised to move on above-average volume during Tuesday's session.
08:37AM 12/01/09
Clarient, Sequenom: Early Volume Plays
Several stocks trading under $5 were poised to move on above-average volume during Monday's session.
09:17AM 11/30/09
NOVAVAX Completes Enrollment In Phase IIa Study Of Seasonal Influenza Vaccine In Older Adults
- Dose-ranging study to compare Novavax's trivalent virus-like-particle (VLP) vaccine to currently marketed flu vaccine, Fluzone(R)
08:05AM 11/30/09
Novavax Plans Offering Of 6.8M Shares; Stock Falls
Drug developer Novavax to offer 6.8 million shares of common stock at $3.30 each; stock falls
10:36AM 11/20/09
DryShips, Novavax: Early Movers
DryShips and Novavax were among the stocks trading near $5 poised to move on above-average volume during Friday's session.
09:27AM 11/20/09
Novavax 3Q Loss Narrows On Cost Cuts
Novavax's 3rd-quarter loss narrows following cost-cutting program
11:13AM 11/06/09



Connect with TheStreet